For Publishers
DiscoveryMetadataPeer reviewHostingPublishing
For Researchers
JoinPublishReviewCollect
Register
Blog
About
Search
Advanced search
My ScienceOpen
Search
For Publishers
For Researchers
Blog
About
1,168
views
24
references
 Top references
cited by
7
    
0 reviews
 Review
0
comments
 Comment
0
recommends
+1 Recommend
2 collections
    0
    shares
      316
      similar
       All similar

      If you have found this article useful and you think it is important that researchers across the world have access, please consider donating, to ensure that this valuable collection remains Open Access.

      State Crime Journal is published by Pluto Journals, an Open Access publisher. This means that everyone has free and unlimited access to the full-text of all articles from our international collection of social science journals. Furthermore Pluto Journals authors don’t pay article processing charges (APCs).

      scite_

      State Crime Journal

      Volume 10, Issue 1
       
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      COVID-19 and the U.S. Health Care Industry: Towards a “Critical Health Criminology” within State Crime Studies

      research-article
      Bookmark

            Abstract

            The core claim of this article is that critical criminology offers us an especially potent framework for interpreting state-corporate crime with the health care industry in the United States as one illustrative case, particularly in the context of the COVID-19 crisis. The unprecedented, surreal pandemic crisis that surfaced in 2020 brought into especially sharp relief many of the core claims of critical criminology in relation to domination, inequality and injustice within a contemporary capitalist political economy, while it also raised the need to broaden critical criminology studies to incorporate the specificities of the health care systems and the pharmaceutical industry. Following this challenge, the article proposes to foster a “critical health criminology” within state-corporate crime research. To do so, this article explores the “big picture” in relation to the COVID-19 pandemic crisis and reveals how it can be understood as a criminological phenomenon. Such a project incorporates the identification of some conceptual issues requiring attention in relation to advancing an enriched form of criminological analysis in these times, and toward building a foundation for a more fully realized twenty-first century criminology.

            Content

            Author and article information

            Journal
            Journal ID (doi): 10.2307/j50005552
            Journal ID (jcode): statecrime
            Title: State Crime Journal
            Publisher: Pluto Journals
            ISSN: 2046-6056
            ISSN: 2046-6064
            Publication date (Print): 1 April 2021
            Volume: 10
            Issue: 1 ( doiID: 10.13169/statecrime.10.issue-1 )
            Pages: 126-146
            Affiliations
            [1 ] University of Scranton
            [2 ] Freie Universität Berlin and Buenos Aires University
            Article
            Publisher ID: statecrime.10.1.0126
            DOI: 10.13169/statecrime.10.1.0126
            SO-VID: f1f7c2de-82a4-4692-8f49-9ec5954ab386
            Copyright © © 2021 International State Crime Initiative
            License:

            All content is freely available without charge to users or their institutions. Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles in this journal without asking prior permission of the publisher or the author. Articles published in the journal are distributed under a http://creativecommons.org/licenses/by/4.0/.

            History
            Categories
            Custom metadata
            lang eng

            ScienceOpen disciplines: Criminology
            Keywords: critical criminology,state-corporate crime,COVID-19 pandemic crisis,health care industry,pharmaceutical industry

            References

            1. Abelson, R. (2020) “Doctors Without Patients: Small Practices in Peril as Business Stalls”, New York Times, 7 May. Available online at: www.nytimes.com/2020/05/05/health/coronavirus-primary-care-doctor.html (accessed 10 June 2020).

            2. Appel, J. M. (2011) “Health ‘Insurance’: A Criminal Enterprise”, HuffPost, 25 May. Available online at: www.huffpost.com/entry/health-insurance-a-crimin_b_341448 (accessed 10 June 2020).

            3. Aronoff, K., Dreier, P., and Kazin, M. (eds) (2020) We Own the Future: Democratic Socialism – American Style. New York: The New Press.

            4. Barak, G. (ed.) (2015) The Routledge International Handbook of the Crimes of the Powerful. New York: Routledge.

            5. Bittle, S., Snider, L., Tombs, S., and Whyte, D. (eds) (2018) Revisiting Crimes of the Powerful: Marxism, Crime and Deviance. New York: Routledge.

            6. Bogdanich, W. (1991) The Great White Lie: Dishonesty, Waste, and Incompetence in the Medical Community. New York: Touchstone.

            7. Bolus, K. (2020) “Moses Taylor Disputes Nurses' Claims in Report”, Sunday Times-Tribune, 12 April. Available online at: www.newsbreak.com/pennsylvania/scranton/news/0OjMJIzV/moses-taylor-disputes-nurses-claims-in-report (accessed 10 June 2020).

            8. Bradley, J. (2020) “Companies Cash in on Scarce Blood Samples Donated by Survivors”, New York Times, 20 May. Available online at: www.nytimes.com/2020/05/01/world/europe/coronavirus-blood-samples.html (accessed 10 June 2020).

            9. Braithwaite, J. (1984) Corporate Crime in the Pharmaceutical Industry. London: Routledge.

            10. Brill, S. (2015) America's Bitter Pill: Money, Politics, Backroom Deals, and the Fight to Fix Our Broken Healthcare System. New York: Random House.

            11. Business Insider (2020) Gilead got FDA approval to keep its experimental coronavirus treatment exclusive for 7 years, 24 March. Available online at: www.businessinsider.com/gileads-potential-coronavirus-treatment-gets-fdas-orphan-drug-label-2020-3?r=DE&IR=T (accessed 10 June 2020).

            12. Butler, D. (2020) “Anguished Nurses Say Pennsylvania Hospital Risked Infecting Cancer Patients, Babies and Staff with Covid-19”, The Washington Post, 11 April. Available online at: www. washingtonpost.com/health/2020/04/11/amid-chaos-anguished-nurses-say-pennsylvania-hospital-risked-infecting-cancer-patients-babies-staff/ (accessed 10 June 2020).

            13. Case, A. and Deaton, A. (2020a) Deaths of Despair and the Future of Capitalism. Princeton: Princeton University Press.

            14. Case, A. and Deaton, A. (2020b) “America Can Afford a World-Class Health System. Why Don't We Have One?”, New York Times, 18 April. Available online at: www.nytimes.com/2020/04/14/opinion/sunday/covid-inequality-health-care.html (accessed 10 June 2020).

            15. Caulkins, J. P. and Reuter, P. (2017) “Dealing More Effectively and Humanely with Illegal Drugs”, in Tonry, M., Nagin, D. S., eds. Reinventing American Criminal Justice. Chicago: University of Chicago Press.

            16. CDC (2020a) America's Drug Overdose Epidemic: Data to Action. Available online at: www.cdc.gov/injury/features/prescription-drug-overdose/index.html (accessed 10 June 2020).

            17. CDC (2020b) U.S. Opioid Prescribing Rate Maps. Available online at: www.cdc.gov/drugoverdose/maps/rxrate-maps.html (accessed 10 June 2020).

            18. Chambliss, W. J., Michalowski, R., and Kramer, R. C. (eds) (2010) State Crime in the Global Age. Portland, OR: Willan.

            19. Chang, H. J. (2010) 23 Things They Don't Tell You About Capitalism. London: Penguin.

            20. Chesney-Lind, M. (2019) “Criminology in the New Era: Confronting Injustice and Inequalities”, The Criminologist, 44: 3–4.

            21. Chesney-Lind, M. (2020) “Feminist Criminology in an Era of Misogyny”, Criminology, 58 (August): 407–422.

            22. Davies, P., Francis, P., and Wyatt, T. (eds) (2014) Invisible Crimes and Social Harms. New York: Palgrave MacMillan.

            23. DeKeseredy, W., and Dragiewicz, M. (eds) (2018) Routledge Handbook of Critical Criminology. 2nd edition. New York: Routledge.

            24. Drucker, J., Silver-Greenberg, J., and Kliff, S. (2020) “How Wealthiest Hospitals Reaped Billions in Bailout”, New York Times, 26 May. Available online at: www.nytimes.com/2020/05/25/business/coronavirus-hospitals-bailout.html (accessed 10 June 2020).

            25. Eyre, E. (2020) Death in Mud Lick: A Coal Country Fight Against the Drug Companies That Delivered the Opioid Epidemic. New York: Scribner.

            26. Fattah, E. (2020) “A Social Scientist Looks at a Global Crisis”, Special Paper: School of Criminology, Simon Fraser University, 30 April. Available online at: https://vancouversun.com/opinion/ezzat-a-fattah-a-social-scientists-view-of-a-global-crisis (accessed 10 June 2020).

            27. Frankel, T., and Roma, T. (2020) “Historical Financial Decline Hits Doctors, Dentists, and Hospitals – Despite Covid-19”, Washington Post, 4 May. Available online at: www.washingtonpost.com/business/2020/05/04/financial-distress-among-doctors-hospitals-despite-covid-19-weighs-heavily-economy/ (accessed 10 June 2020).

            28. Friedrichs, D. O. (2007) “Transnational Crime and Global Criminology: Definitional, Typological, and Contextual Considerations”, Social Justice, 24(2): 4–18.

            29. Friedrichs, D. O. (2010) Trusted Criminals: White Collar Crime in Contemporary Society. 4th ed. Belmont, CA: Wadsworth/Cengage.

            30. Friedrichs, D. O. and Rothe, D. L. (2014) “State-Corporate Crime and Major Financial Institutions: Interrogating an Absence”, State Crime, 3(2): 146–152.

            31. Gelles, D. and Drucker, J. (2020) “With Well-Timed Bets, Insiders Cash In on Sprint for a Vaccine”, New York Times, 26 July.

            32. Ghazi-Tehrani, A. (2019) “Corporate Crime and the State”, in H. Pontell (ed.) Oxford Research Encyclopedia of Criminology and Criminal Justice. New York: Oxford University Press.

            33. Gilead (2020) “Gilead Sciences Statement on Request to Rescind Remdesivir Orphan Drug Designation”. Available online at: www.gilead.com/-/media/gilead-corporate/files/pdfs/company-statements/remdesivir-orphan-drug-designation.pdf (accessed 10 June 2020).

            34. Glanz, J. and Robertson, C. (2020) “Lockdown Delays Cost at Least 36,000 Lives, Data Suggest”, New York Times, 21 May. Available online at: www.nytimes.com/2020/05/20/us/coronavirus-distancing-deaths.html (accessed 10 June 2020).

            35. Goldacre, B. (2013) Bad Pharma: How Drug Companies Mislead Doctors and Harm Patients. New York: Faber and Faber.

            36. Goldstein, M., Silver-Greenberg, J., and Gebeloff, R. (2020) “Push for Profits Left Nursing Homes Struggling to Provide Care”, New York Times, 7 May. Available online at: www.nytimes. com/2020/05/07/business/coronavirus-nursing-homes.html (accessed 10 June 2020).

            37. Gordon, N. and Green, P. (2020) “The Acceleration of Death Precipitated by Covid-19 Exposes State Crime”, Open Democracy, 21 April.

            38. Green, P. and Ward, T. (2004) State Crime. London: Pluto.

            39. Griffin, O. H. and Miller, B. L. (2010) “OxyContin and a Regulation Deficiency of the Pharmaceutical Industry: Rethinking State-Corporate Crime”, Critical Criminology, 19(3): 213–226.

            40. Hagan, J. (2010) Who Are the Criminals? The Politics of Crime Policy from the Age of Roosevelt to the Age of Reagan. Princeton, NJ: Princeton University Press.

            41. Hakim, D., Rabin, R. C., and Rashbaum, W. K. (2019) “Lawsuits Lay Bare Sackler Family Role in Opioid Crisis”, New York Times, 1 April. Available online at: www.nytimes.com/2019/04/01/health/sacklers-oxycontin-lawsuits.html (accessed 10 June 2020).

            42. Hillyard, P., Pantazis, C., Tombs, S., and Gordon, D. (2004) Beyond Criminology: Taking Harm Seriously. London: Pluto Press.

            43. Hsiao, W. C. (2020) “How to Fix American Health Care”, Foreign Affairs (January/February): 96–106.

            44. Hoffman, J. (2020) “Big Pharmacy Chains Accused of Own Role in Opioid Epidemic”, New York Times, 28 May. Available online at: www.nytimes.com/2020/05/27/health/opioids-pharmacy-cvs-litigation.html (accessed 10 June 2020).

            45. Kaplan, S., Goldstein, M., and Stevenson, A. (2020) “Trump's Vaccine Chief Has Vast Ties to Drug Industry, Posing Possible Conflicts”, New York Times, 20 May. Available online at: www.nytimes.com/2020/05/20/health/coronavirus-vaccine-czar.html (accessed 10 June 2020).

            46. Kliff, S. (2020) “Hospitals Knew How to Make Money. Then Coronavirus Happened”, New York Times, 15 May. Available online at: www.nytimes.com/2020/05/15/us/hospitals-revenue-coronavirus.html (accessed 10 June 2020).

            47. Kohrman, N. (2020) “Bitter Pill”, Mother Jones, (July/August): 46–47.

            48. Lerner, S. (2020) “Big Pharma Prepares to Profit from the Coronavirus”, The Intercept, 13 March. Available online at: theintercept.com/2020/03/13/big-pharma-drug-pricing-coronavirus-profits/ (accessed 05 December 2020).

            49. MacFarquhar, N., and Kovaleski, S. F. (2020) “A Pandemic Bright Spot: In Many Places, Less Crime”, New York Times, 27 May. Available online at: www.nytimes.com/2020/05/26/us/coronavirus-crime.html (accessed 10 June 2020).

            50. Macy, B. (2018) Dopesick: Dealers, Doctors, and the Drug Company that Addicted America. New York: Little Brown.

            51. Mazzucato, M. and Momenghalibaf, A. (2020) “Drug Companies Will Make a Killing from Coronavirus”, New York Times, 18 March. Available online at: www.nytimes.com/2020/03/18/opinion/coronavirus-vaccine-cost.html (accessed 10 June 2020).

            52. McNeil, D. B. Jr., and Jacobs, A. (2020) “Rebuking China, Trump Curtails Ties to Hong Kong and Severs Them With W.H.O.”, New York Times, 29 May. Available online at: www.nytimes.com/2020/05/29/us/politics/trump-hong-kong-china-WHO.html (accessed 10 June 2020).

            53. Metcalf, T., Hill, H., and Vickers, E. (2019) “How the Sackler Family Shifted Billions from Opioids to Trusts”, Bloomberg News, 17 December. Available online at: www.bloomberg.com/news/articles/2019-12-17/how-the-sackler-family-shifted-billions-from-opioids-to-trusts (accessed 10 June 2020).

            54. Michalowski, R. (1996) “Critical Criminology and the Critique of Domination: The Story of an Intellectual Movement”, Critical Criminology, 7(1): 9–16.

            55. Michalowski, R. (2009) “Power, Crime and Criminology in the New Imperial Age”, Crime, Law & Social Change, 51: 305–325.

            56. Michalowski, R. (2020) “Trump's Regulatory Reset: Corporate Crime and Social Harm in an Age of Neo-Liberal Deregulation”, Journal of White Collar and Corporate Crime, 1(2): 83–155.

            57. Michalowski, R. and Brown, M. (2020) “Poisoning for Profit: Regulatory Rollback, Public Health, and State-Facilitated Corporate Crime”, Journal of White Collar and Corporate Crime, 1(2): 113–122.

            58. Michalowski, R. J. and Kramer, R. (eds.) (2006) State-Corporate Crime. New Brunswick, NJ: Rutgers University Press.

            59. Mutter, J. C. (2015) Disaster Profiteers: How Natural Disasters Make the Rich Rich and the Poor Even Poorer. New York: St. Martin's Press.

            60. New York Times (2019) “Sound, Fury and Prescription Prices”, 7 July. Available online at: www.nytimes.com/2019/07/06/opinion/drug-pricing-trump.html (accessed 10 June 2020).

            61. Nussbaum, B. (1990) Good Intentions: How Big Business and the Medical Establishment are Corrupting the Fight Against AIDS, Alzheimer's, Cancer, and More. New York: Penguin.

            62. Ornstein, C. and Thomas, K. (2018) “Broken System Lets Doctors Omit Industry Ties in Journals”, New York Times, 9 December.

            63. Paulozzi, L., Baldwin, G., Franklin, G., Kerlikowske, G., Jones, C., Pharm D, Ghiya, N. and Popovic, T. (2012) “CDC Grand Rounds: Prescription Drug Overdoses”, Morbidity and Mortality Weekly Report, 61(1): 10–13.

            64. Porter, E. (2020) “Why America Will Never Get Medicare for All”, New York Times, 15 May. Available online at: www.nytimes.com/2020/03/14/sunday-review/medicare-for-all-america-racism.html (accessed 10 June 2020).

            65. Posner, G. (2020) Pharma: Greed, Lies, and the Poisoning of America. New York: Avid Reader.

            66. Public Citizen (2020) Gilead Must Relinquish Monopoly on Potential Coronavirus Treatment, March 25. Available online at: www.citizen.org/news/gilead-must-relinquish-monopoly-on-potential-coronavirus-treatment/(accessed 10 June 2020).

            67. Reiman, J. and Leighton, P. (2020) The Rich Get Richer and the Poor Get Prison. 12th ed. New York: Routledge.

            68. Reiner, R. (2016) Crime. Malden, MA: Polity Press.

            69. Rorie, M. (ed.) (2020) The Handbook of White-Collar Crime. New York: Wiley.

            70. Rosenfeld, R. (2011) “The Big Picture: 2010 Presidential Address to the American Society of Criminology”, Criminology, 49(10): 1–26.

            71. Rosenthal, E. (2020) “We Knew the Coronavirus Was Coming, Yet We Failed”, New York Times, 6 May. Available online at: www.nytimes.com/2020/05/06/opinion/coronavirus-health-care-market.html (accessed 10 June 2020).

            72. Rothe, D. L. (2009) State Criminality: The Crime of All Crimes. Lanham, MD: Rowman & Littlefield.

            73. Rothe, D. L. and Friedrichs, D. O. (2015) Crimes of Globalization. London: Routledge.

            74. Rothe, D. L. and Kauzlarich, D. (eds.) (2016a) Towards a Victimology of State Crime. New York: Routledge.

            75. Rothe, D. L. and Kauzlarich, D. (2016b) Crimes of the Powerful: An Introduction. London: Routledge.

            76. Ruggiero, V. (2015) Power and Crime. New York: Routledge.

            77. Sanger-Katz, M. (2020) “Why 1.4 Million Health Jobs Have Been Lost During a Huge Health Crisis”, New York Times, 8 May. Available online at: www.nytimes.com/2020/05/08/upshot/health-jobs-plummeting-virus.html (accessed 10 June 2020).

            78. Saphier, N. (2020) Make America Healthy Again: How Bad Behavior and Big Government Caused a Trillion-Dollar Crisis. New York: Broadside Books.

            79. Schwartz, M. D. and Brownstein H. H. (2016) “Critical Criminology”, in Piquero, A. (ed.) The Handbook of Criminological Theory. New York: Wiley Blackwell.

            80. Shaxson, N. (2019) The Financial Curse: How Global Finance is Making Us All Poorer. New York: Grove.

            81. Silver-Greenberg, J., Drucker, J., and Enrich, D. (2020a) “After Billions in Aid, Layoffs Follow”, New York Times, June 8.

            82. Silver-Greenberg, J., Enrich, D., Drucker, J., and Cowley, S. (2020b) “Large Companies Take Bailout Aid in Dubious Gains”, New York Times, 27 April. Available online at: www.nytimes.com/2020/04/26/business/coronavirus-small-business-loans-large-companies.html (accessed 10 June 2020).

            83. Simpson, S. (2019). Personal communication.

            84. Slobodian, Q. (2020) “The Vulture Capitalists are Counting on Us to Do Nothing”, The Nation, 20 April. Available online at: www.thenation.com/article/society/coronavirus-vulture-capitalism/ (accessed 10 June 2020).

            85. Sparrow, M. (2007) License to Steal: Why Fraud Plagues America's Health Care System. Boulder, CO: Westview Press.

            86. Tavernis, S. (2020) “Will the Coronavirus Kill What's Left of Americans' Faith in Washington?”, New York Times, 23 May. Available online at: www.nytimes.com/2020/05/23/us/coronavirus-government-trust.html (accessed 10 June 2020).

            87. Thomas, K. and Abelson, R. (2019) “Drug to Treat Disease to Cost Millions”, New York Times, 26 August. Available online at: www.nytimes.com/2019/08/25/health/drug-prices-rare-diseases.html (accessed 10 June 2020).

            88. Thomas, K. and Grady, D. (2020) “How Upbeat Vaccine News Fueled a Stock Surge, and an Uproar”, New York Times, 24 May. Available online at: www.nytimes.com/2020/05/23/health/coronavirus-vaccine-moderna.html (accessed 10 June 2020).

            89. Thompson, D. (2020) “What's Behind South Korea's Covid-19 Exceptionalism?”, The Atlantic, 6 May. Available online at: www.theatlantic.com/ideas/archive/2020/05/whats-south-koreas-secret/611215/ (accessed 10 June 2020).

            90. Thompson, K. and Abelson, R. (2019) “The $6 Million Drug Claim.”, New York Times, 25 August. Available online at: www.nytimes.com/2019/08/25/health/drug-prices-rare-diseases.html (accessed 10 June 2020).

            91. Tombs, S. (2012) “State-Corporate Symbiosis in the Production of Crime and Harm”, State Crime, 1(2): 170–195.

            92. Topalli, V. and Nikolovska, M. (2020) “The Future of Crime: How Crime Exponentiation Will Change Our Field”, The Criminologist, 45(3): 1–8.

            93. Ugwudike, P. (2015) An Introduction to Critical Criminology. Bristol: Policy Press.

            94. Vaughn, M. G., Jackson, D. B., Testa, A., Holzer, K., Jaegers, L., and Semenza, D. C. (2020) “Health Criminology: New Developments in an Emerging Paradigm”, The Criminologist, 45(3): 9–13.

            95. Vegh Weis, V. (2017) Marxism and Criminology: A History of Criminal Selectivity. Leiden: Brill.

            96. Vogel, K. (2020) “Firm Set Up by G.O.P. Operatives Under Scrutiny Over Virus Contracts”, New York Times, 6 May.

            97. Weiland, N. (2020) “As the Coronavirus Spreads, Legislation on Drug Pricing Remains Stalled.”, New York Times, 28 June.

            98. Wu, T. (2020) “A Corporate Merger Cost Us Ventilators”, New York Times, 13 April. Available online at: www.nytimes.com/2020/04/12/opinion/ventilators-coronavirus.html (accessed 10 June 2020).

            99. Zaitchik, A. (2020) “No Vaccine in Sight”, The New Republic, June: 21–29.

            100. Zorn, J. (2015) “Big Pharma: Life Saver or Criminal Enterprise”, Universal Health Care. Available online at: https://universalhealthct.org/big-pharma-life-saver-or-criminal-enterprise/ (accessed 10 June 2020).

            Comments

            Comment on this article